Pyrrolo[2′,3′:3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types-Reference-Cited by-同舟云学术

Pyrrolo[2′,3′:3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types

Published:2020-09-28 Issue:20 Volume:63 Page:12023-12042
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Spanò Virginia¹,Rocca Roberta²³^ORCID,Barreca Marilia¹⁴,Giallombardo Daniele¹,Montalbano Alessandra¹^ORCID,Carbone Anna¹,Raimondi Maria Valeria¹,Gaudio Eugenio⁴,Bortolozzi Roberta⁵,Bai Ruoli⁶,Tassone Pierfrancesco³,Alcaro Stefano⁷²,Hamel Ernest⁶,Viola Giampietro⁵⁸,Bertoni Francesco⁴⁹,Barraja Paola¹

Affiliation:

1. Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, 90123 Palermo, Italy

2. Net4Science srl, Academic Spinoff, Università Magna Græcia di Catanzaro, Viale Europa, 88100 Catanzaro, Italy

3. Dipartimento di Medicina Sperimentale e Clinica, Università Magna Græcia di Catanzaro, Viale Europa, 88100 Catanzaro, Italy

4. Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland

5. Istituto di Ricerca Pediatrica IRP, Fondazione Città della Speranza, Corso Stati Uniti 4, 35127 Padova, Italy

6. Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, United States

7. Dipartimento di Scienze della Salute, Università Magna Græcia di Catanzaro, Viale Europa, 88100 Catanzaro, Italy

8. Dipartimento di Salute della Donna e del Bambino, Laboratorio di Oncoematologia, Università di Padova, Via Giustiniani 2, 35131 Padova, Italy

9. Oncology Institute of Southern Switzerland, Via Ospedale, 6500 Bellinzona, Switzerland

Funder

National Cancer Institute

Ministero dell?Istruzione, dell?Universit? e della Ricerca

Associazione Italiana per la Ricerca sul Cancro

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c01315

Reference84 articles.

1. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3′,4′,5′-trimethoxyphenyl)-3-(2′-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach

2. Control of microtubule organization and dynamics: two ends in the limelight

3. Microtubules as a target for anticancer drugs

4. Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents

5. Discovery of Novel Quinoline–Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel amide derivatives against VEGFR-2/tubulin with potent antitumor and antiangiogenic activity;Bioorganic Chemistry;2024-10

2. Non-catalytic regioselective synthesis of trans bis-pyrrolo isoxazole cycloadducts in water;RSC Sustainability;2024

3. Synthesis and Evaluation of Biological Activities for a Novel 1,2,3,4-Tetrahydroisoquinoline Conjugate with Dipeptide Derivatives: Insights from Molecular Docking and Molecular Dynamics Simulations;ACS Omega;2023-12-12

4. Development of tubulin polymerization inhibitors as anticancer agents;Expert Opinion on Therapeutic Patents;2023-11-02

5. Green Synthesis and Molecular Docking Study of Some New Thiazoles Using Terephthalohydrazide Chitosan Hydrogel as Ecofriendly Biopolymeric Catalyst;Catalysts;2023-09-20